Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
2001 1
2003 2
2007 1
2009 1
2010 2
2011 1
2012 2
2014 4
2015 2
2016 1
2017 3
2018 3
2019 2
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all
Page 1
[Trastuzumab-associated cardiac dysfunction].
Okada Y, Kanbayashi C, Sato N. Okada Y, et al. Among authors: kanbayashi c. Gan To Kagaku Ryoho. 2010 Apr;37(4):665-9. Gan To Kagaku Ryoho. 2010. PMID: 20414023 Japanese.
Mentorship as Experienced by Women Surgeons in Japan.
Yorozuya K, Kawase K, Akashi-Tanaka S, Kanbayashi C, Nomura S, Tomizawa Y. Yorozuya K, et al. Among authors: kanbayashi c. World J Surg. 2016 Jan;40(1):38-44. doi: 10.1007/s00268-015-3245-8. World J Surg. 2016. PMID: 26404528
Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study.
Tanaka K, Masuda N, Hayashi N, Sagara Y, Hara F, Kadoya T, Matsui A, Miyazaki C, Shien T, Tokunaga E, Hayashi T, Niikura N, Maeda S, Komoike Y, Bando H, Kanbayashi C, Iwata H. Tanaka K, et al. Among authors: kanbayashi c. Breast Cancer. 2021 Jul;28(4):896-903. doi: 10.1007/s12282-021-01225-0. Epub 2021 Feb 18. Breast Cancer. 2021. PMID: 33599914 Free PMC article.
Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study.
Tsuda H, Yoshida M, Akiyama F, Ohi Y, Kinowaki K, Kumaki N, Kondo Y, Saito A, Sasaki E, Nishimura R, Fujii S, Homma K, Horii R, Murata Y, Itami M, Kajita S, Kato H, Kurosumi M, Sakatani T, Shimizu S, Taniguchi K, Tamiya S, Nakamura H, Kanbayashi C, Shien T, Iwata H. Tsuda H, et al. Among authors: kanbayashi c. Jpn J Clin Oncol. 2021 Mar 3;51(3):434-443. doi: 10.1093/jjco/hyaa235. Jpn J Clin Oncol. 2021. PMID: 33420502
Actionable gene alterations in an Asian population with triple-negative breast cancer.
Nagahashi M, Ling Y, Hayashida T, Kitagawa Y, Futamura M, Yoshida K, Kuwayama T, Nakamura S, Toshikawa C, Yamauchi H, Yamauchi T, Kaneko K, Kanbayashi C, Sato N, Miyoshi Y, Tsuchida J, Nakajima M, Shimada Y, Ichikawa H, Lyle S, Takabe K, Okuda S, Wakai T. Nagahashi M, et al. Among authors: kanbayashi c. JCO Precis Oncol. 2018;2:PO.17.00211. doi: 10.1200/po.17.00211. Epub 2018 Jul 23. JCO Precis Oncol. 2018. PMID: 32529167 Free PMC article.
Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer.
Ogiya R, Niikura N, Kumaki N, Yasojima H, Iwasa T, Kanbayashi C, Oshitanai R, Tsuneizumi M, Watanabe KI, Matsui A, Fujisawa T, Saji S, Masuda N, Tokuda Y, Iwata H. Ogiya R, et al. Among authors: kanbayashi c. Oncotarget. 2017 Oct 27;8(61):103671-103681. doi: 10.18632/oncotarget.22110. eCollection 2017 Nov 28. Oncotarget. 2017. PMID: 29262592 Free PMC article.
Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 12 weeks' exemestane exposure in patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study.
Sato N, Masuda N, Morimoto T, Ueno T, Kanbayashi C, Kaneko K, Yasojima H, Saji S, Sasano H, Morita S, Ohno S, Toi M. Sato N, et al. Among authors: kanbayashi c. Cancer Med. 2019 Sep;8(12):5468-5481. doi: 10.1002/cam4.2423. Epub 2019 Jul 30. Cancer Med. 2019. PMID: 31361400 Free PMC article. Clinical Trial.
27 results